Bitcoin Global News (BGN)
March 25, 2019 -- ADVFN Crypto NewsWire -- In June of last
year, the controversial agrochemical and agricultural biotechnology
corporation Monsanto fully rebranded to Bayer Crop Science. Around
that time, the company began other ways to bring change to their
company. One of those was to begin research into blockchain
technology, and partnerships to help reproduce the benefits of
blockchain networks in other big data and research companies within
their own processes.
Most recently, the company is still
dealing with federal court cases in the United States for one of
their most commonly used consumer products. An individual sued the
company after getting cancer, which the root cause of which has
been drawn to use of the product “Round Up.” The results of this
trial should be finalized this month.
However, in a more progressive
light, the company has begun a partnership with BlockApps to help
facilitate this process. BlockApps is one of the offshoots from
leading Ethereum Network developer ConsenSys. The categorize
themselves as a Blockchain-as-a-Service company, helping start ups,
as well as producing technology advancements for Fortune 500
customers such as John Hancock, Minsheng Insurance and BHP
Billiton. The company operates almost completely separate from
Consensys at this point, but the ties will likely remain strong, as
CEO of BlockApps is, ConsenSys founder Joseph Lubin’s
son.
“Blockchain is a tool and not the
destination. We describe ourselves as more of a business network
company these days.” - BlockApps CEO Kieren James-Lubin
BlockApps integrates viable systems
of the customers to the STRATO network. STRATO is an extension of
Ethereum. It is an an open-source Blockchain standard that is
simple for developers to work with. Their customers have come from
a myriad of industries such as finance, insurance, supply chain,
energy, healthcare, and many more. Unlike IBM Hyperledger, R3 and
other enterprise blockchains, STRATO is not static or limited to
vertical use cases, and does not pose a very high cost of
entry.
As a multifaceted, global company,
Bayer Crop Science is looking to this development to “increase our
applications of blockchain, both in our operations and in our
industry.” - Michael Pareles, the global digital strategy manager
of Bayer’s Crop Science division
By: BGN Editorial Staff